Rutgers Cancer Institute of New Jersey offers immunotherapy clinical trial targeting leukemia/lymphoma

Rutgers Cancer Institute of New Jersey is one of a few East Coast sites to offer a clinical trial investigating an experimental drug known as REGN1979 in the treatment of… Source link